Elekta
ISIN SE0000163628
|WKN 896279
Market cap (in EUR)
1,728.30 m
Country
Sweden
Sector
Healthcare
Dividend yield
4.87%
Overview
Description
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America, Europe, Middle East and Africa and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
Healthcare Healthcare Equipment Other Medical Devices Sweden
Financials
Key metrics
| Market capitalisation, EUR | 1,728.30 m |
| EPS, EUR | 0.24 |
| P/B ratio | 1.74 |
| P/E ratio | 18.12 |
| Dividend yield | 4.87% |
Income statement (2023)
| Revenue, EUR | 1,574.77 m |
| Net income, EUR | 113.16 m |
| Profit margin | 7.19% |
What ETF is Elekta in?
There are 37 ETFs which contain Elekta. All of these ETFs are listed in the table below. The ETF with the largest weighting of Elekta is the L&G ROBO Global Robotics and Automation UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
